Wedbush Reiterates Outperform on IDEAYA Biosciences, Maintains $58 Price Target

Benzinga Newsdesk www.benzinga.com Negative 85.5%

Neg 85.5% Neu 0% Pos 0%

Wedbush analyst Robert Driscoll reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $58 price target.